Medicine Description parkintreat 1mg
Parkintreat 1 mg tablets is a medication that functions as a selective, irreversible inhibitor of monoamine oxidase B (MAO-B). By inhibiting this enzyme, rasagiline prevents the breakdown of dopamine in the brain. This action is particularly beneficial for patients with Parkinson's disease, as it helps to increase and prolong the availability of dopamine, a neurotransmitter crucial for regulating movement and coordination. Consequently, Parkintreat aids in correcting the dopamine imbalance present in Parkinson's disease, leading to improved motor function and reduced symptoms such as tremors and rigidity.
Indications and Uses of Parkintreat 1 mg tablets
- Management of Parkinson's disease as an adjunct therapy to levodopa.
- Symptomatic treatment of Parkinson's disease in early-stage patients.
- Improvement of motor function in patients experiencing motor fluctuations.
Side Effects of Parkintreat 1 mg tablets
- Headache
- Nausea
- Insomnia
- Dizziness
- Abdominal pain
- Fatigue
Storage and Handling
Store Parkintreat 1 mg tablets in a cool, dry place away from direct sunlight. Keep out of reach of children and ensure that the product is tightly closed when not in use. Do not use past the expiration date indicated on the packaging.
Patient Advice and Precautions
Patients should take Parkintreat only as prescribed by their healthcare provider. It's crucial to discuss any other medications, supplements, or medical conditions with a healthcare professional to prevent potential drug interactions. Regular follow-up appointments are necessary to monitor the effectiveness of the treatment and adjust dosages if needed. If any severe side effects occur, seek medical help immediately.